News

AddToAny

Google+ Facebook Twitter Twitter

New markers for type 2 diabetes

The presence of death receptors in the blood can be used to measure the risk of developing cardiovascular diseases and type 2 diabetes.

The claim comes in a new paper published by a team from Lund University in Sweden.

The researchers found that people with known risk factors, such as high blood sugar and high blood fats, also have heightened death receptor levels.

Death receptors are activated, for example, in the case of infections when white blood cells that have combated a virus are to be removed.

It was previously known that death receptors in the blood can be measured, but not whether an elevated level was linked to increased cell death in type 2 diabetes and arteriosclerosis.

The results show that increased cell death can be linked to increased levels in the blood of three different members of the same “death receptor family” (TNFR-1, TRAILR-2 and Fas).

Increased cell death is seen in type 2 diabetes as well as arteriosclerosis.

High blood sugar and blood fats subject the body’s blood vessels and insulin-producing beta cells to stress.

Long-term stress damages the cells and can cause the death receptors on the surface of the cell to trigger a cell suicide program within the cell.

Picture credit | iStock

Related Articles

girl computer_CREDIT_shutterstock-58872785

Gamification in biomedical science education

Senior Lecturer in Biomedical Science Jen May outlines the successful implementation of scenario-based learning software.

web_blood-testing_credit_istock-1384651794.png

SPONSORED: The power of automated gel-based ID-cards in routine immunohematology workflows

Immuno-haematology assays are pivotal to the carrying out of blood grouping, antibody screening and transfusions, and represent a critically time-dependent stage in the patient management pathway.

Technician holding a blood sample ready for testing with other human medical samples in the background.-Image credit - Science-Photo-Library-f0243823

Machine learning tool to detect cancer via liquid biopsy

US researchers have developed and tested an innovative machine-learning approach that could one day enable the earlier detection of cancer in patients by using smaller blood draws.

multiple myelomatosis-CREDIT-Science Photo Library-m132099

IBMS research grants

We look at the work of Dr Mosavar Farahani who received an IBMS Research Grant in 2023 to help fund her work on disease progression and skeletal complications in multiple myeloma.

Top